Fee-Based Specialty Insurance Platform Will Benefit From Expanding Third Party Capacity

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published

08 Jan 26

Updated

21 Aug 26

Views

Not Invested

Shared on 21 Aug 26

Fair value Increased 7.62%

ARX: Go Private Buyout Will Drive Future Upside Potential

Accelerant agrees to an all-cash buyout by Thoma Bravo, with the deal still needing shareholder and regulator sign-off before it can close. Rating agencies are reviewing how the takeover could affect the insurance units, while management keeps shrinking the share count and the company gets added to major indexes.

1 view

Shared on 24 Jul 26

Fair value Decreased 15%

ARX: Fee-Based Specialty Platform And New Capacity Will Drive Future Upside

Accelerant lines up a new partner to bring in fresh insurance capacity in the coming years, reinforcing its push to grow by collecting fees rather than taking big balance‑sheet risk. Even as analysts dial back their expectations, the company is expanding key partnerships and setting new performance targets that could reshape what investors expect next.

3 views

Fee-Based Specialty Insurance Platform Will Benefit From Expanding Third Party Capacity

ARX: Go Private Buyout Will Drive Future Upside Potential

ARX: Fee-Based Specialty Platform And New Capacity Will Drive Future Upside

Fair Value vs Share Price

Recent News & Updates

Recent updates

Stay ahead on Accelerant Holdings

Company analysis

CEO & management